The New York Times

Our reporters share a compendium of debuts, discoveries and (sometimes overdue) appearances in the paper.

A Russian researcher, who died from an unknown illness, worked at a remote anti-plague facility. Few foreigners have visited these labs, which dot the former Soviet states, and are shrouded in secrecy.

We asked people who aspire to live long lives about how they hoped to do it and who might have inspired them along the way.

Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly developed treatments are working.

SpudCells may one day produce new medicines and materials. But first scientists have to improve them — and make sure they aren’t misused.

Previous agreements with the tobacco and opioid industries show the difficulty of putting the money in the right hands.

In an interview, Dr. Peter Piot recalled when he first saw the spindly virus under a microscope and reflected on a five-decade career spent fighting two deadly pathogens.

Potent powders can produce a nearly catatonic state, particularly in those who have not tried the drug before.

Since the days of Dr. Alzheimer himself, there has been a dream that severe senility might have an explanation — and a cure. The search for both has never been more urgent.

States said the cash infusion will help bolster efforts to increase vaccinations and identify cases.

As enrollment for Medicare Advantage begins this month, older Americans are confronting fewer options because insurers are discontinuing coverage in many areas.

New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful push for the Covid-19 vaccine.

They thought it might explain why their health had diverged. Instead, it stirred up feelings that weren’t so easily quantified.